Twist Bioscience (TWST) Inventory (2018 - 2026)

Twist Bioscience (TWST) has reported Inventory for 9 consecutive years, with $35.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory rose 35.56% year-over-year to $35.2 million in Q2 2026; TTM through Jun 2026 was $35.2 million, a 35.56% increase from a year earlier, with the FY2025 full-year figure at $28.3 million, up 17.57% from the prior year.
• Inventory was $35.2 million for Q2 2026 at Twist Bioscience, up from $33.5 million in the prior quarter.
• Over five years, Inventory peaked at $44.6 million in Q4 2022 and troughed at $20.9 million in Q1 2025.
• A 5-year average of $33.0 million and a median of $32.5 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 181.54% in 2022 and plunged 31.33% in 2025, its largest moves.
• Over 5 years, Inventory stood at $44.6 million in 2022, then plunged by 30.8% to $30.9 million in 2023, then retreated by 23.8% to $23.5 million in 2024, then surged by 39.99% to $32.9 million in 2025, then increased by 6.8% to $35.2 million in 2026.
• The last three Inventory figures came in at $35.2 million (Q2 2026), $33.5 million (Q1 2026), and $32.9 million (Q4 2025), per Business Quant data.